Page last updated: 2024-11-12

ganu

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

GANU: differs from chlorozotocin by placement of cytotoxic group on C-1 of the glucose ring; less myelosuppressive than chlorozotocin; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9972891
CHEMBL ID3228413
SCHEMBL ID3341237
MeSH IDM0062217

Synonyms (16)

Synonym
ganu
1-(2-chloroethyl)-3-(beta-d-glucopyranosyl)-1-nitrosourea
n-(2-chloroethyl)-n'-beta-d-glucopyranosyl-n-nitrosourea
urea, 1-(2-chloroethyl)-3-(beta-d-glucopyranosyl)-1-nitroso-
1-(2-chloroethyl)-1-nitroso-3-[(2r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]urea
unii-1eu50cxt9p
1eu50cxt9p ,
CHEMBL3228413
SCHEMBL3341237
ZOBLZIKVIHJGRN-JAJWTYFOSA-N
3-(beta-d-glucopyranosyl)-1-(2-chloroethyl)-1-nitrosourea
3-(beta-d-glucopyranosyl)-1-(2 -chloroethyl)-1-nitrosourea
1-(2-chloroethyl)-3-(beta-d-gluco-pyranosyl)-1-nitrosourea
nsc-d-254157
n-(2-chloroethyl)-n'-.beta.-d-glucopyranosyl-n-nitrosourea
1-(2-chloroethyl)-1-nitroso-3-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]urea
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID1123860Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as host survival at 8 mg/kg, ip qd for 3 days measured on day 60 relative to control1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Synthesis and activities of antitumor agents.
AID97591Antitumor activity against Leukemia L1210 cells in BDF1 mice at the dose of 25 mg/kg/day x5 (i.p.) expressed as maximal increase in life-span1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID66146Maximum tolerated dose required antitumor activity against Ehrlich ascites carcinoma cells in male ICR mice.1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID66145Maximum effective dose required for antitumor activity against Ehrlich ascites carcinoma cells in male ICR mice.1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID97588Antitumor activity against Leukemia L1210 cells in BDF1 mice at the dose of 6.25 mg/kg/day x 5 (ip), maximum increase in life-span1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID235241Therapeutic index value for anti-L1210 activity.1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID409956Inhibition of mouse brain MAOB2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
AID1123851Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival days at 8 mg/kg, ip qd for 3 days1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Synthesis and activities of antitumor agents.
AID97593Antitumor activity against Leukemia L1210 cells in BDF1 mice at the dose of 6.25 mg/kg/day x5 (i.p.) expressed as maximal increase in life-span1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID235240Therapeutic index value for anti-Ehrlich activity.1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID97602Antitumor activity against Leukemia L1210 cells in male BDF1 mice at the dose of 6.25 mg/kg/day x5 (i.p.) expressed as maximal increase in life-span1982Journal of medicinal chemistry, Apr, Volume: 25, Issue:4
A new class of nitrosoureas. 4. Synthesis and antitumor activity of disaccharide derivatives of 3,3-disubstituted 1-(2-chloroethyl)-1-nitrosoureas.
AID1123854Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as mean survival days at 8 mg/kg, ip qd for 3 days relative to control1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Synthesis and activities of antitumor agents.
AID1123857Antitumor activity against mouse L1210 cells allografted in BDF1 mouse assessed as increase in life span at 8 mg/kg, ip qd for 3 days relative to control1979Journal of medicinal chemistry, Mar, Volume: 22, Issue:3
Synthesis and activities of antitumor agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (92.86)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 67.04

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index67.04 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index110.69 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (67.04)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]